(Q38220190)

English

Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: its potential use in the treatment of bladder cancers

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: its potential use in the treatment of bladder cancers (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

publication date

12 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929024%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

145

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929024%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1-18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929024%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer

1 reference

31 March 2022

https://opencitations.net/index/coci/api/v1/citations/10.1200/JCO.2012.46.5740

Genome sequencing identifies a basis for everolimus sensitivity

1 reference

31 March 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1226344

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38220190&oldid=1809132922"